Advocate For Change
Lupus Canada has embarked on a national advocacy campaign. By participating in this advocacy campaign you will be urging our elected officials to support our call to action to ask CADTH to revisit their decision and to recommend Belimumab (Benlysta) for public listing to include non renal lupus patients.
Join Lupus Canada to
ADVOCATE FOR CHANGE
To help advocate for those living with lupus please complete the form below